TILSEQ Trademark

Trademark Overview


On Tuesday, October 14, 2014, a trademark application was filed for TILSEQ with the United States Patent and Trademark Office. The USPTO has given the TILSEQ trademark a serial number of 86423216. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 23, 2018. This trademark is owned by Adaptive Biotechnologies Corporation. The TILSEQ trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Scientific research in the field of immune sequencing and analytic services; scientific research in the field of immune repertoire quantitation and sequencing services; medical and scientific research in the field of cancer biology; providing medical and scientific research information in the fields of immune sequencing, cancer biology, pharmaceuticals, and vaccine development; research and development in the fields of cancer biology, vaccines, immunology, pharmaceutical and biotechnology; scientific research in the field of relative and absolute quantitation of adaptive immune cells in a complex biological sample; scientific research for providing relative and absolute quantitation of adaptive immune cells in a solid tumor sample; scientific research for estimating the relative representation of tumor infiltrating T cells in a solid tumor; scientific research for quantifying the presence and clonality of tumor infiltrating lymphocytes in solid tumors; research and development for quan...

Providing medical diagnostic testing for the treatment of cancer; providing medical testing for immune responses to immunotherapy or cancer treatment; providing medical quantitative and diagnostic testing services in the field of cancer biology; providing medical quantitative analysis and testing services in the fields of cancer biology, immunology, pharmaceuticals and vaccines for diagnostic or treatment purposes; medical testing for the prognosis and staging of patients with solid tumors for treatment purposes
tilseq

General Information


Serial Number86423216
Word MarkTILSEQ
Filing DateTuesday, October 14, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 23, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 28, 2015

Trademark Statements


Goods and ServicesScientific research in the field of immune sequencing and analytic services; scientific research in the field of immune repertoire quantitation and sequencing services; medical and scientific research in the field of cancer biology; providing medical and scientific research information in the fields of immune sequencing, cancer biology, pharmaceuticals, and vaccine development; research and development in the fields of cancer biology, vaccines, immunology, pharmaceutical and biotechnology; scientific research in the field of relative and absolute quantitation of adaptive immune cells in a complex biological sample; scientific research for providing relative and absolute quantitation of adaptive immune cells in a solid tumor sample; scientific research for estimating the relative representation of tumor infiltrating T cells in a solid tumor; scientific research for quantifying the presence and clonality of tumor infiltrating lymphocytes in solid tumors; research and development for quantifying the presence and clonality of tumor infiltrating lymphocytes in solid tumors
Goods and ServicesProviding medical diagnostic testing for the treatment of cancer; providing medical testing for immune responses to immunotherapy or cancer treatment; providing medical quantitative and diagnostic testing services in the field of cancer biology; providing medical quantitative analysis and testing services in the fields of cancer biology, immunology, pharmaceuticals and vaccines for diagnostic or treatment purposes; medical testing for the prognosis and staging of patients with solid tumors for treatment purposes

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 21, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 29, 2015
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAdaptive Biotechnologies Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102

Party NameAdaptive Biotechnologies Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102

Trademark Events


Event DateEvent Description
Monday, April 23, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 23, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 13, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 20, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 18, 2017EXTENSION 4 GRANTED
Monday, September 18, 2017EXTENSION 4 FILED
Monday, September 18, 2017TEAS EXTENSION RECEIVED
Tuesday, January 24, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 20, 2017EXTENSION 3 GRANTED
Friday, January 20, 2017EXTENSION 3 FILED
Friday, January 20, 2017TEAS EXTENSION RECEIVED
Tuesday, October 11, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, October 8, 2016EXTENSION 2 GRANTED
Thursday, September 15, 2016EXTENSION 2 FILED
Wednesday, October 5, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 15, 2016TEAS EXTENSION RECEIVED
Wednesday, March 9, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 7, 2016EXTENSION 1 GRANTED
Monday, March 7, 2016EXTENSION 1 FILED
Monday, March 7, 2016TEAS EXTENSION RECEIVED
Tuesday, September 22, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 28, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 28, 2015PUBLISHED FOR OPPOSITION
Wednesday, July 8, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 19, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, June 19, 2015ASSIGNED TO LIE
Tuesday, June 2, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 29, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 28, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 28, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 4, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 4, 2014NON-FINAL ACTION E-MAILED
Thursday, December 4, 2014NON-FINAL ACTION WRITTEN
Wednesday, December 3, 2014ASSIGNED TO EXAMINER
Tuesday, October 21, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, October 17, 2014NEW APPLICATION ENTERED IN TRAM